Uri Yablonka

Uri Yablonka has a diverse work experience, starting with their role as Founder & CEO of Uri Yablonka Ltd from January 2011 to August 2016. Uri then served as EVP Business Development at ACC International Holdings Ltd. from January 2011 to May 2014, where they focused on high-risk, high-reward projects and businesses in the natural resources sector. Since May 2014, Uri has been associated with Brainstorm Cell Therapeutics, first as Chief Operating Officer until March 2017, and then as Executive Director & EVP, Chief Business Officer from March 2017 onwards.

Uri Yablonka holds a Master of Laws (LLM) degree in Commercial Law from Bar-Ilan University. Uri has also obtained several certifications including Aseptic Processing Training & Conducting Investigations, GMP Training, and Design, Conduct & Management of Clinical Trials - Practical GCP Compliance. Additionally, they are an Attorney at law registered with the Israeli Bar Association.